Scientific article
Meta-analysis
OA Policy
English

Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis

Published inPLOS ONE, vol. 14, no. 3, e0213940
Publication date2019
Abstract

Low-molecular-weight heparin (LMWH) is usually recommended for the treatment of cancer-associated thrombosis (CAT) but this treatment requires burdensome daily injections. We did a systematic review to compare the efficacy and safety of direct oral anticoagulants (DOAC), vitamin K antagonists (VKA) and LMWH in patients with CAT.

Keywords
  • Acute Disease
  • Administration
  • Oral
  • Anticoagulants/administration & dosage/adverse effects/therapeutic use
  • Factor Xa Inhibitors/administration & dosage/adverse effects/therapeutic use
  • Female
  • Hemorrhage/etiology
  • Heparin
  • Low-Molecular-Weight/administration & dosage/adverse effects/therapeutic use
  • Humans
  • Male
  • Neoplasms/complications
  • Network Meta-Analysis
  • Recurrence
  • Risk Factors
  • Safety
  • Secondary Prevention
  • Venous Thromboembolism/drug therapy/etiology/prevention & control
  • Vitamin K/antagonists & inhibitors
Citation (ISO format)
ROSSEL, Anne et al. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis. In: PLOS ONE, 2019, vol. 14, n° 3, p. e0213940. doi: 10.1371/journal.pone.0213940
Main files (1)
Article (Published version)
Identifiers
Journal ISSN1932-6203
282views
323downloads

Technical informations

Creation16/10/2020 15:30:00
First validation16/10/2020 15:30:00
Update03/02/2025 11:19:50
Status update03/02/2025 11:19:50
Last indexation14/03/2025 17:07:30
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack